Evidence map›Paper›PMID 40195668›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024

Bibliometric analysis of research hotspots and trends of lncRNA in angiogenesis-related diseases.

Zicong Wang, Bingyan Li, Haixiang Zhou, Junyu Chen, Junye Zhu, Yedi Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zicong WangDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011. cdyy_oph_wang@163.com.
Bingyan LiDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011. lbyi0707@csu.edu.cn.
Haixiang ZhouDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011.
Junyu ChenDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011.
Junye ZhuDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011.
Yedi ZhouDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011. zhouyedi@csu.edu.cn.

Funding

the Natural Science Foundation of Hunan Province, China 2022JJ30869This is an open access article under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International //creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>)
6 · The paper itself

Abstract

objectivesLong noncoding RNAs (lncRNA) play important roles in the pathological processes of angiogenesis-related diseases such as cancer and diabetic retinopathy. This study aims to identify global research trends and hotspots in the field of lncRNAs in angiogenesis-related diseases and to explore future research directions.

methodsRelevant literature published between 2012 and 2022 was retrieved from the Web of Science Core Collection (WoSCC). A total of 1 516 articles on lncRNAs and angiogenesis-related diseases were included for bibliometric analysis. CiteSpace and VOSviewer were used to analyze publication countries, institutions, journals, authors, co-cited references, and key words.

resultsThe number of publications in this field has shown a steadily increasing trend from 2012 to 2022, peaking in 2021. China has the highest number of publications, while the United States ranked highest in centrality. Nanjing Medical University was the most prolific institution. Liu Y was the most productive author, while Wang Y ranked first in co-citation frequency.

conclusionsFrom 2012 to 2022, research on lncRNAs in angiogenesis-related diseases has grown significantly. China leads in publication volume, while the United States holds the most academic influence. Emerging research hotspots such as vascular remodeling and dysfunction point to key directions for future research.

Indexed as

BibliometricsNeoplasmsNeovascularization, PathologicRNA, Long NoncodingAngiogenesisBiomedical ResearchChinaDiabetic RetinopathyHumansRNA, Long Noncodingangiogenesis-related diseasesbibliometricsCiteSpacelong noncoding RNAVOSviewer

Identifiers

PMID40195668
PMCPMC11975513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.